The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Endometrial and Pituitary Responses to the Steroidal Antiprogestin RU 486in Postmenopausal Women
Abstract
The effects of the antiprogestin RU 486 on the human endometrium were investigated. Seventeen postmenopausal women were injected with estradiol (E2) benzoate (0.625 mg/day) for 15 days. Progesterone (P) (25 mg/day) and/or RU 486 (100 or 200 mg/day) were given to groups of 2-3 women during the last 6 days of E2 benzoate treatment. Serial blood samples were drawn for the measurement of plasma E2, P, and LH and FSH. An endometrial biopsy was performed on the last day of treatment, and processed for histology or for assays of DNA polymerase alpha, E2-dehydrogenase (E2DH), and P receptor (PR). Treatment with E2 benzoate alone resulted in a marked decrease of plasma gonadotropins; in those patients who received either P, RU 486, or both, in addition to E2 benzoate, the concentrations of plasma LH and FSH were further decreased to premenopausal levels. In absence of glycerol, the affinity of RU 486 for the endometrial PR (Kd = 0.8 nM) was higher than that of P (Kd = 1.2 nM). Glycerol decreased markedly the affinity of RU 486, whereas the affinity of P for the PR was unchanged. RU 486 had negligible affinity for plasma transcortin. Either P or RU 486, but not both together, induced secretory changes in the endometrium as determined from histologic sections of tissue biopsies. Either P or RU 486 decreased DNA polymerase alpha and increased E2-DH activities in the endometrium. Unexpectedly, when P and RU 486 were given together. E2-DH activity remained at the level found in E2-treated women. In vitro cultures of proliferative endometrium treated with the synthetic progestagen R 5020 or with RU 486 also had increased E2-DH activity; RU 486 counteracted R 5020 effects. We conclude that, contrary to previous results with experimental animals, the anti-P RU 486 has some progestomimetic activity in humans under specific conditions. Paradoxically, when given together with P, RU 486 lost most of its progestomimetic activity in the endometrium and behaved as a pure antagonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burton, K. (1956) · Biochemical Journal · doi:10.1042/bj0620315 · Cited by 14,090
Cited by
Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
Baulieu, E.-E. (1989) · Science · doi:10.1126/science.2781282 · Cited by 483
Self-citationRU486 (MIFEPRISTONE): Mechanisms of Action and Clinical Uses
Cadepond, P., Ulmann, M., & Baulieu, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.129 · Cited by 424
Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
Meyer, M. E., Pornon, A., Ji, J. W., Bocquel, M. T., Chambon, P., & Gronemeyer, H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07613.x · Cited by 328
Chabbert-Buffet, N., Meduri, G., Bouchard, P., & Spitz, I. M. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi002 · Cited by 310
Kettel, L. M., Murphy, A. A., Mortola, J. F., Liu, J. H., Ulmann, A., & Yen, S. S. C. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54531-2 · Cited by 151
Metadata
- Authors
- GRAVANIS, A., SCHAISON, G., GEORGE, M., DE BRUX, J., SATYASWAROOP, P. G., BAULIEU, E. E., & ROBEL, P.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1985-01
- Volume
- 60
- Issue
- 1
- Pages
- 156-163
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123015098
- Cited by
- 189
- References
- 1
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endometrial and Pituitary Responses to the Steroidal Antiprogestin RU 486in Postmenopausal Women. https://app.cochat.ai/papers/10.1210/jcem-60-1-156
- The paper
- GRAVANIS, A., SCHAISON, G., GEORGE, M., DE BRUX, J., SATYASWAROOP, P. G., BAULIEU, E. E., & ROBEL, P. (1985). Endometrial and Pituitary Responses to the Steroidal Antiprogestin RU 486in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-60-1-156
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.